Abstract
Background
Prior osteoporotic fractures are strongly associated with subsequent fractures. To prevent this, the diagnosis of osteoporosis following an osteoporotic fracture is important. The measurement of bone mineral density (BMD) is the first step in the diagnosis and management of osteoporosis. Therefore, this study aimed 1) to evaluate the rate of BMD measurement after osteoporotic fracture in the Korean population, and 2) to determine whether the rate of BMD measurement after osteoporotic fracture changed between 2005 and 2010.
Methods
Using the database of the Health Insurance Review Assessment Service (HIRA), we identified patients with osteoporotic fractures (hip, spine, humerus, and wrist fractures) in 2005 and 2010. BMD examinations were evaluated by using procedure codes and medicines, exclusively approved for osteoporosis treatment.
Osteoporosis is a common health care concern in elderly populations that is characterized by compromised bone strength.[12] Osteoporosis results in osteoporotic fracture in hip, spine, humerus, and wrist.[34] The lifetime risk of these osteoporotic fractures is about 60% in Korean women.[5]
It is well-known that patients with an osteoporotic fracture have higher risk of a subsequent fracture than those with no previous fracture.[67] That is osteoporotic fracture offers physicians an important opportunity to initiate secondary prevention.[89] Thus, secondary prevention has been recommended by several guidelines for osteoporosis.
Bone mineral density (BMD) measurement is the first important step to investigate and manage patients with osteoporosis. There were few studies on the rate of BMD measurement after osteoporotic fracture in Korea, and whether there was a change of rate of BMD measurement after fractures.
Therefore, our purpose was 1) to evaluate the rate of BMD measurement after osteoporotic fracture in Korean population, and 2) determine whether the rate of BMD measurement after osteoporotic fracture changed between 2005 and 2010 in Korea.
We used data from nationwide claims database of Health Insurance Review Assessment Service (HIRA). About 97% of the Korean populations are included in this national insurance system. Patients pay about 30% of total medical cost, and Korean governments reimburse the remaining 70% of medical cost to medical institute after the HIRA reviews all the medical claims data. The medical claims data include demographic information (age and gender), diagnoses using the International Classification of Disease, Tenth Revision (ICD-10) codes and procedures for diagnosis and treatment using codes in both of inpatients and outpatients care.
Thus, virtually all information about health care utilization is available from the HIRA database. Several epidemiologic studies have used this national claim database.[101112]
We analyzed patients aged over 50 years who were diagnosed with osteoporotic fracture by physician at 2005 and 2010.
We identified patients with hip, spine, humerus and wrist fractures on 2005 and 2010. To identify patients with these fractures, we used the diagnostic codes using the ICD-10 (hip [S720 and S721], spine [M484, M485, S220, S221, and S320], humerus [S422 and S423] and wrist fractures [S525 and S526]) and the procedure codes according to each anatomic site.[1314]
If an individual with fracture had more than one outpatient visits or admissions within the time period of six months, the cases were not counted as separate.[1516]
Double recording was avoided by including only one record when a person had more than one record in the HIRA database. If a patient had both spine and wrist fractures, only the first episode was counted.[17]
Data were obtained from the HIRA on patients who had experienced a hip, spine, humerus or wrist fracture and had undergone BMD examinations within 6 months before and after osteoporotic fractures.
The procedure codes (HC 341 to HC 344) for these examinations included dual energy X-ray absorptiometry (DXA) scans (single site, HC 341; multiple sites, HC 342), quantitative computed tomography scans (HC 343), and other methods, including ultrasound (HC 344).
In addition, patients who administrated with at least one of the exclusive medicines approved for osteoporosis treatment were also considered as patients who were measured with BMD, because the medicines for osteoporosis was available only after BMD measurement during study period in Korea. These medications included bisphosphonates (alendronate, etidronate, pamidronate, risedronate, zoledronate), selective estrogen receptor modulator (raloxifene), and calcitonin. Estrogen replacement therapy, calcium and vitamin D supplements were not included because they had another indication such as osteopenia.
The rates of BMD examinations were estimated within 6 months before and after osteoporotic fractures. Significance of differences was determined with use of a χ2 test. Statistical analyses were performed using SAS for windows, version 9.4 (SAS Inc., Cary, NC, USA).
The 156,190 patients with osteoporotic fractures were identified in 2005, and 192,556 in 2010, respectively. Between 2005 and 2010, the rate of BMD measurement significantly increased from 42.0% to 53.9% (P<0.001) (Table 1).
The rate of BMD measurement dramatically increased from 19.7% to 37.9% in men, while the rate of BMD measurement changed from 48.3 to 57.9 % in women (Fig. 1).
The percentage of women who received a bone density examination was significantly higher for those of men in both 2005 and 2010.
The present study demonstrates that the rate of BMD measurement after osteoporotic fractures was around 50%, and significantly increased between 2005 and 2010, especially in men.
Many studies have indicated that BMD measurement following an osteoporotic fracture was performed in less than 15% of patients with osteoporotic fracture.[1819]
The rate of BMD measurement after fracture seems to be unsatisfactory in Korea. It might be the reason the limitation of Korean health-care reimbursement system during the study period. The reimbursement system has allowed the screening of osteoporosis in patients just after fracture since 2015. It might suppress the clinical inertia for initiation of a required action such as screening of osteoporosis in patients with fracture before 2015.
However, the rate of BMD measurement increased between 2005 and 2010, which is sure to be positive direction for health care. There are some possible explanations on our results.
First, physician's awareness on osteoporosis might increase, although we could not evaluate the level of physician's awareness on osteoporosis. Some studies showed that the increase of awareness in physicians lead to increase of screening of osteoporosis in patients with fracture.[2021] Second, patients' awareness on osteoporosis might increase as well.
The strength of this study is that we evaluated the rate of osteoporosis screening in patients with osteoporotic fractures in a large, population-based national cohort.
There were limitations in this study. First, we included patients who had undergone BMD examinations within 6 months ‘before’ as well as ‘after’ osteoporotic fractures, because the obtained dataset from HIRA could not be distinguished between before and after osteoporotic fractures. Although it might result in bias, BMD measurement is mostly taken after osteoporotic fractures.
Second, we could not perform comprehensive analyses to define the factors associated with low rate of BMD measurement after fracture, because we could not access to individual records of subjects. Further studies are necessary to identify the risk factors of low investigation of osteoporosis in these patients.
Despite these limitations, this study would be helpful in terms of understanding current practice patterns after fracture in Korea. Our results showed that about a half of patients with osteoporotic fractures had BMD measurement, and the rate of screening for osteoporosis increased between 2005 and 2010.
ACKNOWLEDGEMENT
This research was supported by grants (HI15C1189) of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea.
References
1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000; 17:1–45.
2. Peck WA. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94:646–650.
3. Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005; 16:Suppl 2. S3–S7.
4. Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001; 12:417–427.
5. Kim JW, Jeon YJ, Baek DH, et al. Percentage of the population at high risk of osteoporotic fracture in South Korea:analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int. 2014; 25:1313–1319.
6. Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007; 297:387–394.
7. Langsetmo L, Goltzman D, Kovacs CS, et al. Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res. 2009; 24:1515–1522.
8. Ganda K, Schaffer A, Pearson S, et al. Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int. 2014; 25:1345–1355.
9. Nakayama A, Major G, Holliday E, et al. Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int. 2016; 27:873–879.
10. Yoon HK, Lee YK, Ha YC. Characteristics of patients diagnosed with osteoporosis in South Korea: results from the national claim registry. J Bone Metab. 2017; 24:59–63.
11. Park C, Jang S, Lee A, et al. Incidence and mortality after proximal humerus fractures over 50 years of age in South Korea: national claim data from 2008 to 2012. J Bone Metab. 2015; 22:17–21.
12. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.
13. Park C, Ha YC, Jang S, et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.
14. Yoo JH, Moon SH, Ha YC, et al. Osteoporotic fracture: 2015 position statement of the Korean society for bone and mineral research. J Bone Metab. 2015; 22:175–181.
15. Lau E, Ong K, Kurtz S, et al. Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am. 2008; 90:1479–1486.
16. Kang HY, Yang KH, Kim YN, et al. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data. BMC Public Health. 2010; 10:230.
17. Gong HS, Oh WS, Chung MS, et al. Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am. 2009; 91:2376–2380.
18. Giangregorio LM, Leslie WD. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res. 2010; 25:1400–1405.
19. Metge CJ, Leslie WD, Manness LJ, et al. Postfracture care for older women: gaps between optimal care and actual care. Can Fam Physician. 2008; 54:1270–1276.